Informations générales (source: ClinicalTrials.gov)
RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer: Concordance With the "Standard" Testing Method From Tumor Tissue and Review of Associated Timelines and Costs (RASANC)
Observational
Association des Gastroentérologues Oncologues (Voir sur ClinicalTrials)
juillet 2015
août 2017
29 juin 2024
This study will evaluate the concordance of RAS mutation detection between the results
obtained from circulating tumor DNA and those obtained with the "standard" method
(testing from tumor tissue).
Etablissements
Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
AP-HP - Hôpital Avicenne | Thomas Aparicio, Pr | Contact (sur clinicalTrials) | |||
AP-HP - Hôpital Cochin | Romain Coriat, Pr | Contact (sur clinicalTrials) | |||
AP-HP - Hôpital Europeen Georges Pompidou | Julien Taieb, Pr | Contact (sur clinicalTrials) | |||
AP-HP - Hôpital Henri Mondor-Albert Chenevier | Christophe Tournigand, Pr | Contact (sur clinicalTrials) | |||
AP-HP - Hôpital Saint Antoine | Thierry André, Pr | Contact (sur clinicalTrials) | |||
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
CHU Poitiers - Poitiers - France | David Tougeron, Pr | Contact (sur clinicalTrials) | |||
CHU Robert Debré - Reims - France | Olivier Bouché, Pr | Contact (sur clinicalTrials) | |||
Hopital Mermoz - Lyon - France | Gérard Lledo, Dr | Contact (sur clinicalTrials) | |||
Hopital Saint-Louis - Paris - France | Jean-Marc Gornet, Dr | Contact (sur clinicalTrials) | |||
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
CH Longjumeau et Sud - Longjumeau - France | J Ezenfis, Dr | Contact (sur clinicalTrials) | |||
Hopital Béclère - Clamart - France | L Marthey, Dr | Contact (sur clinicalTrials) | |||
Hopital Kremlin-Bicêtre - Kremlin-Bicêtre - France | Anne Thirot- Bidault, Dr | Contact (sur clinicalTrials) | |||
Hôpital Pitié Salpêtrière - Paris - France | Jean-Baptiste Bachet, Dr | Contact (sur clinicalTrials) | |||
Hôpital Trousseau - Tours - France | Thierry Lecomte, Pr | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Pathologically confirmed metachronous or synchronous metastatic colorectal cancer
- No prior chemotherapy with the exception of adjuvant chemotherapy completed ≥ 6
months prior to enrollment
- Signed written informed consent obtained prior to any study specific screening
procedures
- Patients willing to provide a blood sample for Translational Research
- Pathologically confirmed metachronous or synchronous metastatic colorectal cancer
- No prior chemotherapy with the exception of adjuvant chemotherapy completed ≥ 6
months prior to enrollment
- Signed written informed consent obtained prior to any study specific screening
procedures
- Patients willing to provide a blood sample for Translational Research
- No tumor block available
- Previous malignancy in the last 5 years
- Medical, sociological, psychological or legal conditions that would not permit the
patient to sign informed consent